• Mineralocorticoid receptor antagonists may stave off renal replacement therapy in CKD

    3 monthes ago - By Healio

    In a real-world outpatient population, mineralocorticoid receptor antagonist use in patients with chronic kidney disease was associated with lower rates of renal replacement therapy initiation compared with nonuse, researchers reported.
    According to data published in Hypertension, mineralocorticoid receptor antagonist use in patients with an estimated glomerular filtration rate of 10 mL/min/1.73 m2 to 60 mL/min/1.73 m2 was tied to lower rates of chronic hemodialysis, peritoneal dialysis or kidney transplantation.
    “Preventing kidney failure with replacement therapy is an
    Read more ...